Strengths

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● With regards to fundamentals, the enterprise value to sales ratio is at 1.07 for the current period. Therefore, the company is undervalued.

● The company appears to be poorly valued given its net asset value.

● The company is one of the best yield companies with high dividend expectations.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Sales forecast by analysts have been recently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's earnings growth outlook lacks momentum and is a weakness.